Figure 7.
Analysis of fibroblasts of controls (n = 3) and LGMDR1 patients (n = 3) treated with the GSK-3 inhibitors, tideglusib and VP0.7.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.